Dec. 03 2025
Source Page: Talquetamab for treating relapsed and refractory multiple myeloma after 3 or more treatmentsDec. 03 2025
Source Page: Child maltreatment: when to suspect maltreatment in under 18sDec. 03 2025
Source Page: Child maltreatment: when to suspect maltreatment in under 18sDec. 03 2025
Source Page: Child maltreatment: when to suspect maltreatment in under 18sDec. 03 2025
Source Page: Child maltreatment: when to suspect maltreatment in under 18sDec. 03 2025
Source Page: Talquetamab for treating relapsed and refractory multiple myeloma after 3 or more treatmentsDec. 03 2025
Source Page: Glofitamab with gemcitabine and oxaliplatin for treating relapsed or refractory diffuse large B-cell lymphomaDec. 03 2025
Source Page: Child maltreatment: when to suspect maltreatment in under 18sDec. 03 2025
Source Page: Child maltreatment: when to suspect maltreatment in under 18sDec. 03 2025
Source Page: Child maltreatment: when to suspect maltreatment in under 18s